世界のバイオサージェリー用シーラント＆止血剤市場予測（～2028年）：止血鉗子、内部組織シーラント、癒着バリア

• 英文タイトル：Global Biosurgery Sealants and Hemostats Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028

• レポートコード：GIR-22E7663 • 出版社/出版日：GlobalInfoResearch / 2022年5月 • レポート形態：英文、PDF、94ページ • 納品方法：Eメール（2~3営業日） • 産業分類：医療機器

• 販売価格（消費税別）

Single User	￥515,040 (USD3,480)	▷ お問い合わせ
Multi User	￥772,560 (USD5,220)	▷ お問い合わせ
Corporate User	￥1,030,080 (USD6,960)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

バイオサージェリー用シーラント＆止血剤市場レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。 GlobalInfoResearchの最新の調査によると、世界のバイオサージェリー用シーラント＆止血剤の市場規模は2021年のxxx米ドルから2028年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。 バイオサージェリー用シーラント＆止血剤市場は種類と用途によって区分されます。2017年～2028年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。 種類別セグメントは次をカバーします。 ・止血鉗子、内部組織シーラント、癒着バリア 用途別セグメントは次のように区分されます。 ・病院、診療所、外傷センター、外来手術センター 世界のバイオサージェリー用シーラント＆止血剤市場の主要な市場プレーヤーは以下のとおりです。 ・CR Bard、Johnson & Johnson、Baxter International、Medtronic、CSL Behring、CryoLife、Cohera Medical、Sanofi、Pfizer 地域別セグメントは次の地域・国をカバーします。 ・北米（米国、カナダ、メキシコ） ・ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア） ・アジア太平洋（日本、中国、韓国、インド、東南アジア、オーストラリア） ・南アメリカ（ブラジル、アルゼンチン、コロンビア） ・中東およびアフリカ（サウジアラビア、UAE、エジプト、南アフリカ） 本調査レポートの内容は計15章あります。 ・第1章では、バイオサージェリー用シーラント＆止血剤製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。 ・第2章では、主要なバイオサージェリー用シーラント＆止血剤メーカーの企業概要、2019年～2022年までのバイオサージェリー用シーラント＆止血剤の価格、販売量、売上、市場シェアを掲載しています。 ・第3章では、主要なバイオサージェリー用シーラント＆止血剤メーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。 ・第4章では、2017年～2028年までの地域別バイオサージェリー用シーラント＆止血剤の販売量、売上、成長性を示しています。 ・第5、6章では、2017年～2028年までのバイオサージェリー用シーラント＆止血剤の種類別と用途別の市場規模、市場シェアと成長率を掲載しています。 ・第7、8、9、10、11章では、2017年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2028年までの主要地域でのバイオサージェリー用シーラント＆止血剤市場予測を収録しています。 ・第12章では、主要な原材料、主要なサプライヤー、およびバイオサージェリー用シーラント＆止血剤の産業チェーンを掲載しています。 ・第13、14、15章では、バイオサージェリー用シーラント＆止血剤の販売チャネル、販売業者、顧客、調査結果と結論、付録、データソースなどについて説明します。 ***** 目次(一部) ***** ・市場概要 ・メーカー情報（企業概要、製品概要、販売量、価格、売上）：CR Bard、Johnson & Johnson、Baxter International、Medtronic、CSL Behring、CryoLife、Cohera Medical、Sanofi、Pfizer ・メーカー別市場シェア ・地域別市場分析2017年-2028年 ・種類別分析2017年-2028年：止血鉗子、内部組織シーラント、癒着バリア ・用途別分析2017年-2028年：病院、診療所、外傷センター、外来手術センター ・バイオサージェリー用シーラント＆止血剤の北米市場規模2017年-2028年：アメリカ、カナダ、メキシコ ・バイオサージェリー用シーラント＆止血剤のヨーロッパ市場規模2017年-2028年：ドイツ、イギリス、フランス、ロシア、イタリア ・バイオサージェリー用シーラント＆止血剤のアジア市場規模2017年-2028年：中国、日本、韓国、インド、東南アジア、オーストラリア ・バイオサージェリー用シーラント＆止血剤の南米市場規模2017年-2028年：ブラジル、アルゼンチン ・バイオサージェリー用シーラント＆止血剤の中東・アフリカ市場規模2017年-2028年：サウジアラビア、トルコ、エジプト、南アフリカ ・原材料および産業チェーン ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論

The Biosurgery Sealants and Hemostats market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Biosurgery Sealants and Hemostats market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Hospitals accounting for % of the Biosurgery Sealants and Hemostats global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Hemostats segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Biosurgery Sealants and Hemostats include CR Bard, Johnson & Johnson, Baxter International, Medtronic, and CSL Behring, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Biosurgery Sealants and Hemostats market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Hemostats
Internal Tissue Sealants
Adhesion Barriers
Market segment by Application can be divided into
Hospitals
Clinics and Trauma Centers
Ambulatory Surgical Centers
The key market players for global Biosurgery Sealants and Hemostats market are listed below:
CR Bard
Johnson & Johnson
Baxter International
Medtronic
CSL Behring
CryoLife
Cohera Medical
Sanofi
Pfizer
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Biosurgery Sealants and Hemostats product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Biosurgery Sealants and Hemostats, with price, sales, revenue and global market share of Biosurgery Sealants and Hemostats from 2019 to 2022.
Chapter 3, the Biosurgery Sealants and Hemostats competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Biosurgery Sealants and Hemostats breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Biosurgery Sealants and Hemostats market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Biosurgery Sealants and Hemostats.
Chapter 13, 14, and 15, to describe Biosurgery Sealants and Hemostats sales channel, distributors, customers, research findings and conclusion, appendix and data source.

レポート目次

---

1 Market Overview
1.1 Biosurgery Sealants and Hemostats Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Biosurgery Sealants and Hemostats Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 Hemostats
1.2.3 Internal Tissue Sealants
1.2.4 Adhesion Barriers
1.3 Market Analysis by Application
1.3.1 Overview: Global Biosurgery Sealants and Hemostats Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Hospitals
1.3.3 Clinics and Trauma Centers
1.3.4 Ambulatory Surgical Centers
1.4 Global Biosurgery Sealants and Hemostats Market Size & Forecast
1.4.1 Global Biosurgery Sealants and Hemostats Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Biosurgery Sealants and Hemostats Sales in Volume (2017-2028)
1.4.3 Global Biosurgery Sealants and Hemostats Price (2017-2028)
1.5 Global Biosurgery Sealants and Hemostats Production Capacity Analysis
1.5.1 Global Biosurgery Sealants and Hemostats Total Production Capacity (2017-2028)
1.5.2 Global Biosurgery Sealants and Hemostats Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Biosurgery Sealants and Hemostats Market Drivers
1.6.2 Biosurgery Sealants and Hemostats Market Restraints
1.6.3 Biosurgery Sealants and Hemostats Trends Analysis
2 Manufacturers Profiles
2.1 CR Bard
2.1.1 CR Bard Details
2.1.2 CR Bard Major Business
2.1.3 CR Bard Biosurgery Sealants and Hemostats Product and Services
2.1.4 CR Bard Biosurgery Sealants and Hemostats Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 Johnson & Johnson
2.2.1 Johnson & Johnson Details
2.2.2 Johnson & Johnson Major Business
2.2.3 Johnson & Johnson Biosurgery Sealants and Hemostats Product and Services
2.2.4 Johnson & Johnson Biosurgery Sealants and Hemostats Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 Baxter International
2.3.1 Baxter International Details
2.3.2 Baxter International Major Business
2.3.3 Baxter International Biosurgery Sealants and Hemostats Product and Services
2.3.4 Baxter International Biosurgery Sealants and Hemostats Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 Medtronic
2.4.1 Medtronic Details
2.4.2 Medtronic Major Business
2.4.3 Medtronic Biosurgery Sealants and Hemostats Product and Services
2.4.4 Medtronic Biosurgery Sealants and Hemostats Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 CSL Behring
2.5.1 CSL Behring Details
2.5.2 CSL Behring Major Business
2.5.3 CSL Behring Biosurgery Sealants and Hemostats Product and Services
2.5.4 CSL Behring Biosurgery Sealants and Hemostats Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 CryoLife
2.6.1 CryoLife Details
2.6.2 CryoLife Major Business
2.6.3 CryoLife Biosurgery Sealants and Hemostats Product and Services
2.6.4 CryoLife Biosurgery Sealants and Hemostats Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7 Cohera Medical
2.7.1 Cohera Medical Details
2.7.2 Cohera Medical Major Business
2.7.3 Cohera Medical Biosurgery Sealants and Hemostats Product and Services
2.7.4 Cohera Medical Biosurgery Sealants and Hemostats Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8 Sanofi
2.8.1 Sanofi Details
2.8.2 Sanofi Major Business
2.8.3 Sanofi Biosurgery Sealants and Hemostats Product and Services
2.8.4 Sanofi Biosurgery Sealants and Hemostats Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9 Pfizer
2.9.1 Pfizer Details
2.9.2 Pfizer Major Business
2.9.3 Pfizer Biosurgery Sealants and Hemostats Product and Services
2.9.4 Pfizer Biosurgery Sealants and Hemostats Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Biosurgery Sealants and Hemostats Breakdown Data by Manufacturer
3.1 Global Biosurgery Sealants and Hemostats Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Biosurgery Sealants and Hemostats Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Biosurgery Sealants and Hemostats
3.4 Market Concentration Rate
3.4.1 Top 3 Biosurgery Sealants and Hemostats Manufacturer Market Share in 2021
3.4.2 Top 6 Biosurgery Sealants and Hemostats Manufacturer Market Share in 2021
3.5 Global Biosurgery Sealants and Hemostats Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Biosurgery Sealants and Hemostats Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Biosurgery Sealants and Hemostats Market Size by Region
4.1.1 Global Biosurgery Sealants and Hemostats Sales in Volume by Region (2017-2028)
4.1.2 Global Biosurgery Sealants and Hemostats Revenue by Region (2017-2028)
4.2 North America Biosurgery Sealants and Hemostats Revenue (2017-2028)
4.3 Europe Biosurgery Sealants and Hemostats Revenue (2017-2028)
4.4 Asia-Pacific Biosurgery Sealants and Hemostats Revenue (2017-2028)
4.5 South America Biosurgery Sealants and Hemostats Revenue (2017-2028)
4.6 Middle East and Africa Biosurgery Sealants and Hemostats Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Biosurgery Sealants and Hemostats Sales in Volume by Type (2017-2028)
5.2 Global Biosurgery Sealants and Hemostats Revenue by Type (2017-2028)
5.3 Global Biosurgery Sealants and Hemostats Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Biosurgery Sealants and Hemostats Sales in Volume by Application (2017-2028)
6.2 Global Biosurgery Sealants and Hemostats Revenue by Application (2017-2028)
6.3 Global Biosurgery Sealants and Hemostats Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Biosurgery Sealants and Hemostats Sales by Type (2017-2028)
7.2 North America Biosurgery Sealants and Hemostats Sales by Application (2017-2028)
7.3 North America Biosurgery Sealants and Hemostats Market Size by Country
7.3.1 North America Biosurgery Sealants and Hemostats Sales in Volume by Country (2017-2028)
7.3.2 North America Biosurgery Sealants and Hemostats Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Biosurgery Sealants and Hemostats Sales by Type (2017-2028)
8.2 Europe Biosurgery Sealants and Hemostats Sales by Application (2017-2028)
8.3 Europe Biosurgery Sealants and Hemostats Market Size by Country
8.3.1 Europe Biosurgery Sealants and Hemostats Sales in Volume by Country (2017-2028)
8.3.2 Europe Biosurgery Sealants and Hemostats Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Biosurgery Sealants and Hemostats Sales by Type (2017-2028)
9.2 Asia-Pacific Biosurgery Sealants and Hemostats Sales by Application (2017-2028)
9.3 Asia-Pacific Biosurgery Sealants and Hemostats Market Size by Region
9.3.1 Asia-Pacific Biosurgery Sealants and Hemostats Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Biosurgery Sealants and Hemostats Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Biosurgery Sealants and Hemostats Sales by Type (2017-2028)
10.2 South America Biosurgery Sealants and Hemostats Sales by Application (2017-2028)
10.3 South America Biosurgery Sealants and Hemostats Market Size by Country
10.3.1 South America Biosurgery Sealants and Hemostats Sales in Volume by Country (2017-2028)
10.3.2 South America Biosurgery Sealants and Hemostats Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Biosurgery Sealants and Hemostats Sales by Type (2017-2028)
11.2 Middle East & Africa Biosurgery Sealants and Hemostats Sales by Application (2017-2028)
11.3 Middle East & Africa Biosurgery Sealants and Hemostats Market Size by Country
11.3.1 Middle East & Africa Biosurgery Sealants and Hemostats Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Biosurgery Sealants and Hemostats Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Biosurgery Sealants and Hemostats and Key Manufacturers
12.2 Manufacturing Costs Percentage of Biosurgery Sealants and Hemostats
12.3 Biosurgery Sealants and Hemostats Production Process
12.4 Biosurgery Sealants and Hemostats Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Biosurgery Sealants and Hemostats Typical Distributors
13.3 Biosurgery Sealants and Hemostats Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer

---